跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AURO-TRANDOLAPRIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AURO-TRANDOLAPRIL
Authorized
STANDARD
AURO-TRANDOLAPRIL
auro pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f5fe882f4250584c
Company
auro pharma inc
Type
Standard
Approval Details
Approval Id
f5fe882f4250584c
Drug Approval Canada Name
AURO-TRANDOLAPRIL
Product Name
AURO-TRANDOLAPRIL
Status
Marketed
Status Date
2018-09-27
Original Market Date
2018-09-27
Din
02471868
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.04
Atc Original
C09AA10 TRANDOLAPRIL
Atc Name
c 09 aa 10
Aig Number
0131524001
Company Name
auro pharma inc
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
TRANDOLAPRIL
0.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f5fe882f4250584c
Type
Standard
Back to Health Canada Approvals